These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 32892195)

  • 1. Prognostic Value of Biomarkers in Cardiac Allograft Vasculopathy following Heart Transplantation: A Literature Review.
    Habibi S; Ghaffarpasand E; Shojaei F; Alihashemi M; Kahe F; Zahedi Tajrishi F; Chi G
    Cardiology; 2020; 145(11):693-702. PubMed ID: 32892195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting the development of cardiac allograft vasculopathy.
    Seki A; Fishbein MC
    Cardiovasc Pathol; 2014; 23(5):253-60. PubMed ID: 24972526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Layered Fibrotic Plaques Are the Predominant Component in Cardiac Allograft Vasculopathy: Systematic Findings and Risk Stratification by OCT.
    Clemmensen TS; Holm NR; Eiskjær H; Løgstrup BB; Christiansen EH; Dijkstra J; Barkholt TØ; Terkelsen CJ; Maeng M; Poulsen SH
    JACC Cardiovasc Imaging; 2017 Jul; 10(7):773-784. PubMed ID: 28330670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transplant Vasculopathy Versus Native Atherosclerosis: Similarities and Differences.
    Weis M; Weis M
    Transplantation; 2024 Jun; 108(6):1342-1349. PubMed ID: 37899386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computational Analysis of Routine Biopsies Improves Diagnosis and Prediction of Cardiac Allograft Vasculopathy.
    Peyster EG; Janowczyk A; Swamidoss A; Kethireddy S; Feldman MD; Margulies KB
    Circulation; 2022 May; 145(21):1563-1577. PubMed ID: 35405081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological and Fibrotic Mechanisms in Cardiac Allograft Vasculopathy.
    Jansen MA; Otten HG; de Weger RA; Huibers MM
    Transplantation; 2015 Dec; 99(12):2467-75. PubMed ID: 26285017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac allograft vasculopathy: Insights on pathogenesis and therapy.
    Lee F; Nair V; Chih S
    Clin Transplant; 2020 Mar; 34(3):e13794. PubMed ID: 31991002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic and Functional Profiling of CD16-Dependent Natural Killer Activation Identifies Patients at Higher Risk of Cardiac Allograft Vasculopathy.
    Paul P; Picard C; Sampol E; Lyonnet L; Di Cristofaro J; Paul-Delvaux L; Lano G; Nicolino-Brunet C; Ravis E; Collart F; Dignat-George F; Dussol B; Sabatier F; Mouly-Bandini A
    Circulation; 2018 Mar; 137(10):1049-1059. PubMed ID: 29097449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor A is associated with the subsequent development of moderate or severe cardiac allograft vasculopathy in pediatric heart transplant recipients.
    Daly KP; Stack M; Eisenga MF; Keane JF; Zurakowski D; Blume ED; Briscoe DM
    J Heart Lung Transplant; 2017 Apr; 36(4):434-442. PubMed ID: 27865734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Timing of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor initiation and allograft vasculopathy progression and outcomes in heart transplant recipients.
    Asleh R; Briasoulis A; Pereira NL; Boilson BA; Edwards BS; Adigun R; Maltais S; Daly RC; Lerman A; Kushwaha SS
    ESC Heart Fail; 2018 Dec; 5(6):1118-1129. PubMed ID: 30019530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of longitudinal myocardial deformation by 2-dimensional speckle-tracking echocardiography in heart transplant recipients: relation to coronary allograft vasculopathy.
    Clemmensen TS; Løgstrup BB; Eiskjær H; Poulsen SH
    J Heart Lung Transplant; 2015 Feb; 34(2):195-203. PubMed ID: 25108908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial Perfusion Reserve and Strain-Encoded CMR for Evaluation of Cardiac Allograft Microvasculopathy.
    Erbel C; Mukhammadaminova N; Gleissner CA; Osman NF; Hofmann NP; Steuer C; Akhavanpoor M; Wangler S; Celik S; Doesch AO; Voss A; Buss SJ; Schnabel PA; Katus HA; Korosoglou G
    JACC Cardiovasc Imaging; 2016 Mar; 9(3):255-66. PubMed ID: 26965729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The composition of ectopic lymphoid structures suggests involvement of a local immune response in cardiac allograft vasculopathy.
    Huibers MM; Gareau AJ; Vink A; Kruit R; Feringa H; Beerthuijzen JM; Siera-de Koning E; Peeters T; de Jonge N; de Weger RA; Lee TD
    J Heart Lung Transplant; 2015 May; 34(5):734-45. PubMed ID: 25655346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Routine C4d immunohistochemistry in cardiac allografts: Long-term outcomes.
    Husain AN; Mirza KM; Fedson SE
    J Heart Lung Transplant; 2017 Dec; 36(12):1329-1335. PubMed ID: 28988608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukotriene B4: A potential mediator and biomarker for cardiac allograft vasculopathy.
    Wang D; Tediashvili G; Kim D; Hu X; Luikart H; Renne T; Tian A; Nadeau KC; Velden J; Schrepfer S; Khush KK
    J Heart Lung Transplant; 2024 Aug; 43(8):1336-1347. PubMed ID: 38670297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PET Assessment of Epicardial Intimal Disease and Microvascular Dysfunction in Cardiac Allograft Vasculopathy.
    Chih S; Chong AY; Erthal F; deKemp RA; Davies RA; Stadnick E; So DY; Overgaard C; Wells G; Mielniczuk LM; Beanlands RSB
    J Am Coll Cardiol; 2018 Apr; 71(13):1444-1456. PubMed ID: 29598865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. European Association of Cardiovascular Imaging/Cardiovascular Imaging Department of the Brazilian Society of Cardiology recommendations for the use of cardiac imaging to assess and follow patients after heart transplantation.
    Badano LP; Miglioranza MH; Edvardsen T; Colafranceschi AS; Muraru D; Bacal F; Nieman K; Zoppellaro G; Marcondes Braga FG; Binder T; Habib G; Lancellotti P;
    Eur Heart J Cardiovasc Imaging; 2015 Sep; 16(9):919-48. PubMed ID: 26139361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular cell adhesion molecule-1 is induced on vascular endothelia and medial smooth muscle cells in experimental cardiac allograft vasculopathy.
    Ardehali A; Laks H; Drinkwater DC; Ziv E; Drake TA
    Circulation; 1995 Aug; 92(3):450-6. PubMed ID: 7543379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravascular ultrasound for cardiac allograft vasculopathy detection.
    Mendiz OA; Gamboa P; Renedo MF; Lev GA; Favaloro LE; Bertolotti AM
    Clin Transplant; 2021 Feb; 35(2):e14167. PubMed ID: 33237578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Endothelin-1 With Accelerated Cardiac Allograft Vasculopathy and Late Mortality Following Heart Transplantation.
    Parikh RV; Khush K; Pargaonkar VS; Luikart H; Grimm D; Yu M; Okada K; Honda Y; Yeung AC; Valantine H; Fearon WF
    J Card Fail; 2019 Feb; 25(2):97-104. PubMed ID: 30543947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.